Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 29,882 shares at $31.00 ($909K) on 2012-11-06, disclosed to the SEC on 2012-11-08.
Scheduled sale ($909k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.68 | 13,100 | $389K | 42.8% |
| 2 | $31.00 | 16,782 | $520K | 57.2% |
| Total | $30.42 avg | 29,882 | $909K | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |